During the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition, the Lymphoma Hub spoke to Adam Olszewski, Brown University, Providence, US. We asked, Is mosunetuzumab safe and effective for elderly patients with untreated diffuse large B-cell lymphoma?
The Lymphoma Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy
Is mosunetuzumab safe and effective for elderly patients with untreated DLBCL?
Is mosunetuzumab safe and effective for elderly patients with untreated DLBCL?
Olszewski reports the results of a phase I/II clinical trial of mosunetuzumab as a first-line treatment for elderly and unfit patients with diffuse large B-cell lymphoma.
Related articles
Newsletter
Subscribe to get the best content related to lymphoma & CLL delivered to your inbox